183 related articles for article (PubMed ID: 9192978)
21. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
22. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
[TBL] [Abstract][Full Text] [Related]
23. Cyclin D1 and retinoblastoma susceptibility gene alterations in non-small cell lung cancer.
Marchetti A; Doglioni C; Barbareschi M; Buttitta F; Pellegrini S; Gaeta P; La Rocca R; Merlo G; Chella A; Angeletti CA; Dalla Palma P; Bevilacqua G
Int J Cancer; 1998 Jan; 75(2):187-92. PubMed ID: 9462706
[TBL] [Abstract][Full Text] [Related]
24. [Clinical significance of cyclin Dl expression in non-small cell lung cancer].
Dworakowska D
Pneumonol Alergol Pol; 2005; 73(3):297-300. PubMed ID: 16989170
[TBL] [Abstract][Full Text] [Related]
25. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
26. [Expression of cyclin D1 and vascular endothelial growth factor(VEGF) in non-small cell lung carcinoma and their association with the prognosis].
Liang RY; Liao ZS; Jiang SP; Zhang W; Li JG; Zheng DH
Ai Zheng; 2003 Jan; 22(1):86-90. PubMed ID: 12561444
[TBL] [Abstract][Full Text] [Related]
27. Loss of p16 and/or pRb protein expression in NSCLC. An immunohistochemical and prognostic study.
Chen JT; Chen YC; Chen CY; Wang YC
Lung Cancer; 2001; 31(2-3):163-70. PubMed ID: 11165395
[TBL] [Abstract][Full Text] [Related]
28. Cyclin D1 protein expression in lung cancer.
Yang WI; Chung KY; Shin DH; Kim YB
Yonsei Med J; 1996 Apr; 37(2):142-50. PubMed ID: 8711937
[TBL] [Abstract][Full Text] [Related]
29. Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast.
Simpson JF; Quan DE; O'Malley F; Odom-Maryon T; Clarke PE
Am J Pathol; 1997 Jul; 151(1):161-8. PubMed ID: 9212742
[TBL] [Abstract][Full Text] [Related]
30. Changes in expression of pRb, p16 and cyclin D1 in non-small cell lung cancer: an immunohistochemical study.
Malusecka E; Zborek A; Krzyzowska-Gruca S
Folia Histochem Cytobiol; 1999; 37(1):19-24. PubMed ID: 10091946
[TBL] [Abstract][Full Text] [Related]
31. RB growth control evasion in lung cancer.
Caputi M; Esposito V; Groger AM; De Luca A; Pacilio C; Dekan G; Giordano GG; Baldi F; Wolner E; Giordano A
Anticancer Res; 1998; 18(4A):2371-4. PubMed ID: 9703881
[TBL] [Abstract][Full Text] [Related]
32. Expression of p16 and lack of pRB in primary small cell lung cancer.
Yuan J; Knorr J; Altmannsberger M; Goeckenjan G; Ahr A; Scharl A; Strebhardt K
J Pathol; 1999 Nov; 189(3):358-62. PubMed ID: 10547597
[TBL] [Abstract][Full Text] [Related]
33. Cyclin D1 overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survival.
Ratschiller D; Heighway J; Gugger M; Kappeler A; Pirnia F; Schmid RA; Borner MM; Betticher DC
J Clin Oncol; 2003 Jun; 21(11):2085-93. PubMed ID: 12775733
[TBL] [Abstract][Full Text] [Related]
34. Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line.
Hochhauser D; Schnieders B; Ercikan-Abali E; Gorlick R; Muise-Helmericks R; Li WW; Fan J; Banerjee D; Bertino JR
J Natl Cancer Inst; 1996 Sep; 88(18):1269-75. PubMed ID: 8797766
[TBL] [Abstract][Full Text] [Related]
35. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
[TBL] [Abstract][Full Text] [Related]
36. Cyclin D1 protein expression and function in human breast cancer.
Bartkova J; Lukas J; Müller H; Lützhøft D; Strauss M; Bartek J
Int J Cancer; 1994 May; 57(3):353-61. PubMed ID: 8168995
[TBL] [Abstract][Full Text] [Related]
37. [The cyclin A, B1, D1 and E expression in advanced non-small cell lung cancer--stages IIIB-IV (preliminary report)].
Kosacka M; Piesiak P; Porebska I; Korzeniewska A; Jankowska R
Pol Merkur Lekarski; 2011 Apr; 30(178):253-8. PubMed ID: 21595169
[TBL] [Abstract][Full Text] [Related]
38. Determination of the prognostic value of cyclin D1 overexpression in breast cancer.
McIntosh GG; Anderson JJ; Milton I; Steward M; Parr AH; Thomas MD; Henry JA; Angus B; Lennard TW; Horne CH
Oncogene; 1995 Sep; 11(5):885-91. PubMed ID: 7675447
[TBL] [Abstract][Full Text] [Related]
39. Cyclin D1 expression is regulated by the retinoblastoma protein.
Müller H; Lukas J; Schneider A; Warthoe P; Bartek J; Eilers M; Strauss M
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):2945-9. PubMed ID: 8159685
[TBL] [Abstract][Full Text] [Related]
40. Regulated expression of the retinoblastoma susceptibility gene in mammary carcinoma cells restores cyclin D1 expression and G1-phase control.
Gjetting T; Lukas J; Bartek J; Strauss M
Biol Chem Hoppe Seyler; 1995 Jul; 376(7):441-6. PubMed ID: 7576242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]